What is Crypto Compa's earnings per share (EPS)?

Crypto Compa (CRCW) reported diluted earnings per share of $0.00 for fiscal year 2024. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Crypto Compa Financials

CRCW

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows Crypto Compa (CRCW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CRCW FY2024 2026-04-22

Equity issuance appears to have been the main survival tool as operating scale and liquid assets nearly disappeared.

Shares outstanding rose from 22.2M to 2.58B, showing how heavily the company leaned on equity rather than internally generated funds as a financing tool. Yet FY2024 ended with only $1.8K of cash against $6.7M of liabilities, so that capital appears to have gone toward keeping the balance sheet functioning, not restoring operating depth.

FY2023 gross margin dropped to -55.9% after previously positive levels, meaning the core activity no longer covered its own direct costs before any overhead or financing burden. That points to a business that was not just subscale but economically inverted: sales were consuming resources at the gross-profit line instead of helping absorb fixed expenses.

The current ratio was 0.0003x in FY2024, indicating that near-term obligations overwhelmed near-term resources rather than merely stretching them. Because current assets were essentially just $1.8K of cash, there was little else on the balance sheet to turn into near-term liquidity, leaving day-to-day flexibility dependent on outside support.

Financial Health Signals

Financial Profile 5/100

Based on FY2024 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Crypto Compa's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage

Crypto Compa has a moderate D/E ratio of -1.00. This balance of debt and equity financing earns a leverage score of 32/100.

Liquidity

Crypto Compa's current ratio of 0.00 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

$0.00

Crypto Compa earned $0.00 per diluted share (EPS) in fiscal year 2024. This represents an increase of 100.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$2K

YoY-97.6%

5Y CAGR+1.8%

Crypto Compa held $2K in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

2.58B

Crypto Compa had 2.58B shares outstanding in fiscal year 2024. This represents an increase of 734.2% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

CRCW Income Statement

Metric	FY24	FY25	FY22	FY21	FY20	FY19
Revenue	N/A	$208K-66.4%	$620K+42.6%	$435K+2917.7%	$14K	N/A
Cost of Revenue	N/A	$314K-15.0%	$369K+34.9%	$274K	N/A	N/A
Gross Profit	N/A	-$116K-146.5%	$250K+55.7%	$161K+1016.4%	$14K	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	$1.9M+26.7%	$1.5M	N/A	N/A
Operating Income	N/A	N/A	-$3.8M-85.1%	-$2.1M	N/A	N/A
Interest Expense	N/A	N/A	$1.8M+10635.4%	$16K-75.9%	$68K	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	$2K
Net Income	N/A	N/A	-$5.7M-620.8%	-$786K	N/A	N/A
EPS (Diluted)	$0.00	$-0.05	$-0.24	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Revenue	$7K+68.4%	$4K+48.1%	$3K	N/A	$10K+4.7%	$10K-37.7%	$16K-43.9%	$28K
Cost of Revenue	N/A	N/A	N/A	N/A	$7K-4.8%	$8K+407.1%	$2K-98.2%	$84K
Gross Profit	$7K+68.4%	$4K+48.1%	$3K	N/A	$3K+39.4%	$2K-85.2%	$14K+121.6%	-$66K
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$293K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	-$386K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$538K	N/A	N/A	N/A	N/A	$193K-3.5%	$200K	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$1.6M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	$0.00	$0.00	$0.00	N/A	$0.00	$0.00	$0.00	N/A

CRCW Balance Sheet

Metric	FY24	FY25	FY22	FY21	FY20	FY19
Total Assets	$2K-97.6%	$73K-95.3%	$1.6M+2.4%	$1.5M+4928.3%	$30K+1776.2%	$2K
Current Assets	$2K-97.6%	$73K-62.0%	$192K+18.6%	$162K+435.6%	$30K+1776.2%	$2K
Cash & Equivalents	$2K-97.6%	$73K-34.0%	$111K+46.1%	$76K+187.5%	$26K+1534.1%	$2K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	$4K	N/A
Goodwill	$0	N/A	$740K0.0%	$740K	N/A	N/A
Total Liabilities	$6.7M+21.8%	$5.5M+19.2%	$4.6M+82.0%	$2.5M+4.5%	$2.4M+24.3%	$2.0M
Current Liabilities	$6.7M	N/A	$4.5M+88.2%	$2.4M+6.5%	$2.2M+19.0%	$1.9M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$6.7M-23.4%	-$5.4M-77.4%	-$3.1M-201.2%	-$1.0M+57.6%	-$2.4M-22.9%	-$1.9M
Retained Earnings	-$53.4M-14.2%	-$46.8M-18.3%	-$39.5M-16.7%	-$33.9M-2.4%	-$33.1M-9.3%	-$30.3M

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Total Assets	$1.5M+34156.8%	$4K-38.3%	$7K+293.3%	$2K-81.8%	$10K-77.7%	$44K+0.9%	$43K-40.9%	$73K
Current Assets	$447K+10347.7%	$4K-38.3%	$7K+293.3%	$2K-81.8%	$10K-77.7%	$44K+0.9%	$43K-40.9%	$73K
Cash & Equivalents	$447K+10347.7%	$4K-38.3%	$7K+293.3%	$2K-73.5%	$7K-78.8%	$31K+43.4%	$22K-70.0%	$73K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$0	N/A	N/A	$0	N/A	N/A	N/A	N/A
Total Liabilities	$8.8M+19.7%	$7.4M+6.7%	$6.9M+3.0%	$6.7M-17.1%	$8.1M+51.2%	$5.3M-6.7%	$5.7M+4.2%	$5.5M
Current Liabilities	$8.8M+19.7%	$7.4M+6.7%	$6.9M+3.1%	$6.7M+10.8%	$6.0M	N/A	$5.5M	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$7.3M+0.2%	-$7.4M-6.7%	-$6.9M-3.0%	-$6.7M+17.0%	-$8.1M-52.3%	-$5.3M+6.8%	-$5.7M-4.8%	-$5.4M
Retained Earnings	-$56.7M-3.0%	-$55.0M-1.9%	-$54.0M-1.1%	-$53.4M-2.2%	-$52.2M-7.3%	-$48.7M-3.6%	-$47.0M-0.5%	-$46.8M

CRCW Cash Flow Statement

Metric	FY24	FY25	FY22	FY21	FY20	FY19
Operating Cash Flow	N/A	N/A	-$1.9M-1167.9%	-$152K	N/A	N/A
Capital Expenditures	N/A	N/A	$50K	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	-$2.0M	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	-$50K+93.6%	-$786K	N/A	N/A
Financing Cash Flow	N/A	N/A	$2.0M+104.0%	$988K+740.0%	$118K	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Operating Cash Flow	-$767K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$1.2M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

CRCW Financial Ratios

Metric	FY24	FY25	FY22	FY21	FY20	FY19
Gross Margin	N/A	-55.9%-96.3pp	40.4%+3.4pp	37.0%-63.0pp	100.0%	N/A
Operating Margin	N/A	N/A	-621.3%-142.8pp	-478.5%	N/A	N/A
Net Margin	N/A	N/A	-914.0%-733.3pp	-180.8%	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	-363.8%-312.1pp	-51.7%	N/A	N/A
Current Ratio	0.00	N/A	0.04-0.0	0.07+0.1	0.01+0.0	0.00
Debt-to-Equity	-1.00+0.0	-1.01+0.5	-1.51+1.0	-2.50-1.5	-1.01-0.0	-1.00
FCF Margin	N/A	N/A	-319.6%	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Gross Margin	100.0%0.0pp	100.0%0.0pp	100.0%	N/A	28.5%+7.1pp	21.4%-68.9pp	90.3%+324.5pp	-234.1%
Operating Margin	-5424.5%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-22897.9%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-111.3%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	0.05+0.1	0.000.0	0.000.0	0.000.0	0.00	N/A	0.01	N/A
Debt-to-Equity	-1.20-0.2	-1.000.0	-1.000.0	-1.000.0	-1.000.0	-1.010.0	-1.010.0	-1.01
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$6.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

EarthLabs Inc SPOFF

$35.3M

Unitronix UTRX

$807K

SUIC Worldwide Holdings Ltd SUIC

$9.7M

Banxa Hldgs BNXAF

$40.2M

Kontrol Technologies Corp KNRLF

$2.5M

Frequently Asked Questions

What are Crypto Compa's total assets?

Crypto Compa (CRCW) had $2K in total assets as of fiscal year 2024, including both current and long-term assets.

How many shares does Crypto Compa have outstanding?

Crypto Compa (CRCW) had 2.58B shares outstanding as of fiscal year 2024.

What is Crypto Compa's current ratio?

Crypto Compa (CRCW) had a current ratio of 0.00 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

What is Crypto Compa's debt-to-equity ratio?

Crypto Compa (CRCW) had a debt-to-equity ratio of -1.00 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

Why is Crypto Compa's debt-to-equity ratio negative or unusual?

Crypto Compa (CRCW) has negative shareholder equity of -$6.7M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

How financially healthy is Crypto Compa?

Crypto Compa (CRCW) scores 5 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.